Trending - Altmetric
- CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal AdenocarcinomaLast mentioned on Wed Jan 27 2021
- Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK-Rearranged/TP53-Mutant NSCLC via Noxa ExpressionLast mentioned on Sun Jan 24 2021
- Understanding Academic Medical Centers: Simone’s MaximsLast mentioned on Wed Jan 27 2021
- Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed GlioblastomaLast mentioned on Wed Jan 27 2021
- The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting ImpactsLast mentioned on Mon Dec 28 2020
- Similarities in Risk for COVID-19 and Cancer DisparitiesLast mentioned on Tue Jan 26 2021
- BRCA2, ATM, and CDK12 defects differentially shape prostate tumor driver genomics and clinical aggressionLast mentioned on Fri Jan 22 2021
- Tissue hypoxia and alterations in microvascular architecture predict glioblastoma recurrence in humansLast mentioned on Wed Jan 27 2021
- BTK Inhibitors in Cancer Patients with COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte)Last mentioned on Wed Dec 30 2020
- Genome-wide copy number alterations in circulating tumor DNA as a novel biomarker in high grade serous ovarian cancer patientsLast mentioned on Fri Jan 01 2021
- Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancerLast mentioned on Wed Jan 27 2021
- Concomitant MEK and Cyclin Gene Alterations: Implications for Response to Targeted TherapeuticsLast mentioned on Tue Jan 26 2021
- Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in GlioblastomaLast mentioned on Sat Jan 16 2021
- Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent MannerLast mentioned on Thu Jan 14 2021
- ARID1A mutation may define an immunologically active subgroup in patients with microsatellite-stable colorectal cancerLast mentioned on Fri Jan 15 2021
- TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of GliomasLast mentioned on Thu Jan 07 2021
- Physical Activity and Cancer Outcomes: A Precision Medicine ApproachLast mentioned on Mon Jan 25 2021
- Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast CancerLast mentioned on Thu Dec 31 2020
Pages